ConductScience.org, home

Paper5331901

The antitumor activity of Escherichia coli L-asparaginase.

Roberts J and 2 others. Cancer Res, 1966. Cited by 118 papers, by iCite.

Cite this record

ConductScience Library. The antitumor activity of Escherichia coli L-asparaginase. Papers, record 5331901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5331901

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The antitumor activity of Escherichia coli L-asparaginase.
PubMed
Journal
Cancer Res
PubMed
Year
1966
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
118
iCite
Revised in PubMed
2009-10-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roberts JJ
2Prager MDM D
3Bachynsky NN

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmidohydrolasesMajor topic
Antineoplastic AgentsMajor topic
Escherichia coliMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Mice

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMIDTitleJournalYearIn PapersSource
40237204Biochemical and Biophysical Divergences between Two Escherichia coli l-Asparaginase II Variants: Potential for Using EcA2-K12 as a Biosimilar.Biochemistry2025https://conductscience.org/library/papers/40237204PubMed
40195325L-asparaginase is a PAR2 N-terminal protease that unmasks the PAR2 tethered ligand.Cell Death Discov2025https://conductscience.org/library/papers/40195325PubMed
39065214Extracellular Membrane Vesicles of Escherichia coli Induce Apoptosis of CT26 Colon Carcinoma Cells.Microorganisms2024https://conductscience.org/library/papers/39065214PubMed
38792133Substrate Affinity Is Not Crucial for Therapeutic L-Asparaginases: Antileukemic Activity of Novel Bacterial Enzymes.Molecules2024https://conductscience.org/library/papers/38792133PubMed
36828987Biochemical characterization of extremozyme L-asparaginase from Pseudomonas sp. PCH199 for therapeutics.AMB Express2023https://conductscience.org/library/papers/36828987PubMed
36310372The E. coli L-asparaginase V27T mutant: structural and functional characterization and comparison with theoretical predictions.FEBS Lett2022https://conductscience.org/library/papers/36310372PubMed
36152020The dimeric form of bacterial l-asparaginase YpAI is fully active.FEBS J2023https://conductscience.org/library/papers/36152020PubMed
32297090Production, characterization and bioinformatics analysis of L-asparaginase from a new Stenotrophomonas maltophilia EMCC2297 soil isolate.AMB Express2020https://conductscience.org/library/papers/32297090PubMed
31387272Microalgal Enzymes with Biotechnological Applications.Mar Drugs2019https://conductscience.org/library/papers/31387272PubMed
30900037Experimental and bioinformatics study for production of L-asparaginase from Bacillus licheniformis: a promising enzyme for medical application.AMB Express2019https://conductscience.org/library/papers/30900037PubMed
25573198Effect of premedications in a murine model of asparaginase hypersensitivity.J Pharmacol Exp Ther2015https://conductscience.org/library/papers/25573198PubMed
22895060Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.Bioengineered2013https://conductscience.org/library/papers/22895060PubMed
22042277
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
J Pediatr Hematol Oncol2011https://conductscience.org/library/papers/22042277PubMed
18046445Fresh frozen plasma contains free asparagine and may replace the plasma asparagine pool during L-asparaginase therapy.Leukemia2008https://conductscience.org/library/papers/18046445PubMed
8004756Liposomal palmitoyl-L-asparaginase: characterization and biological activity.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8004756PubMed
5000866L-Asparaginase from Proteus vulgaris.Appl Microbiol1971https://conductscience.org/library/papers/5000866PubMed
4995652Purification and properties of L-asparaginase from Serratia marcescens.J Bacteriol1971https://conductscience.org/library/papers/4995652PubMed
4970225New procedures for purification of L-asparaginase with high yield from Escherichia coli.J Bacteriol1968https://conductscience.org/library/papers/4970225PubMed
4904782[Inhibition of malignant human neoplasms with L-asparaginase].Klin Wochenschr1969https://conductscience.org/library/papers/4904782PubMed
4904781[L-asparaginase and leukemia].Klin Wochenschr1969https://conductscience.org/library/papers/4904781PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5331901

GET https://conductscience.org/api/papers/v1/5331901/cited_by?page=2